- Home
- SPCE vs KPTI Comparison
SPCE vs KPTI Comparison
Compare SPCE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | KPTI |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | 694 | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.8M | 197.3M |
| IPO Year | 2017 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SPCE | KPTI |
|---|---|---|
| Price | $2.39 | $8.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $3.06 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 10.8M | 527.9K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.84 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,544,000.00 | ★ $146,067,000.00 |
| Revenue This Year | $2,270.73 | N/A |
| Revenue Next Year | $880.03 | $22.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $2.13 | $3.65 |
| 52 Week High | $5.59 | $10.99 |
Technical Indicators
Market Signals| Indicator | SPCE | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 36.13 | 56.09 |
| Support Level | $2.29 | $5.84 |
| Resistance Level | $2.68 | $9.00 |
| Average True Range (ATR) | 0.21 | 0.64 |
| MACD | -0.06 | 0.07 |
| Stochastic Oscillator | 1.07 | 55.35 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).